Arena Pharmaceuticals Inc EBIT margin
Mi az Arena Pharmaceuticals Inc EBIT margin?
A EBIT margin az Arena Pharmaceuticals Inc - -1,133,840.74%
Mi a EBIT margin meghatározása?
EBIT margin is a profitability ratio that measures earnings of the company as a percentage of revenue without taking into account the effect of taxes and interest.
ttm (trailing twelve months)
EBIT margin measures the profitability and operational efficiency of a company. It compares the amount of money that remains after the cost of goods and all operating expenses are subtracted from net revenue to sales. EBIT margin is calculated as earnings before interest and taxes divided by net revenue.
EBIT and EBIT margin evaluate how well a business manages its operations. Interest and taxes are not operating expenses and don’t impact operating efficiency. EBIT margin is usually used to compare operational efficiency and profitability of companies within the same industry. Taxes can vary by location thus excluding them from the calculation gives a better basis for comparing different companies.
EBIT and operating income are often used interchangeably, but there is a difference between them, which can cause the numbers to give different results. The key difference is that operating income does not include non-operating income, non-operating expenses, and other income.
EBIT margin a Health Care szektor a NASDAQ-on cégekben a Arena Pharmaceuticals Inc -hoz képest
Mit csinál Arena Pharmaceuticals Inc?
Arena Pharmaceuticals, Inc. is a biopharmaceutical company founded in 1997 and located in San Diego, California. The company has small molecule drugs in development for possible clinical utility in multiple therapeutic areas
ebit margin -hoz hasonló cégek Arena Pharmaceuticals Inc
- Nimy Resources Ltd nak EBIT margin -1,962,988.89% van
- Akora Resources Ltd nak EBIT margin -1,900,440.63% van
- Deepti Alloy Steel nak EBIT margin -1,676,280.26% van
- Carpinienne de Participations nak EBIT margin -1,474,500.00% van
- Thin Film Electronics ASA nak EBIT margin -1,362,200.00% van
- Allogene Therapeutics Inc nak EBIT margin -1,342,523.81% van
- Arena Pharmaceuticals Inc nak EBIT margin -1,133,840.74% van
- Aurum Resources Ltd nak EBIT margin -887,391.20% van
- Eastern Metals nak EBIT margin -812,601.10% van
- Willow Biosciences nak EBIT margin -803,860.14% van
- Psyched Wellness nak EBIT margin -703,101.31% van
- Cannon Resources Ltd nak EBIT margin -666,400.00% van
- Tamboran Resources Ltd nak EBIT margin -530,273.27% van